Journal article
Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A.
- Abstract:
-
Azithromycin is an effective treatment for uncomplicated infections with Salmonella enterica serovar Typhi and serovar Paratyphi A (enteric fever), but there are no clinically validated MIC and disk zone size interpretative guidelines. We studied individual patient data from three randomized controlled trials (RCTs) of antimicrobial treatment in enteric fever in Vietnam, with azithromycin used in one treatment arm, to determine the relationship between azithromycin treatment response and the ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
The Wellcome Trust
More from this funder
University of Oxford-Li Ka Shing Global Health Foundation
More from this funder
Bibliographic Details
- Publisher:
- American Society of Microbiology Publisher's website
- Journal:
- Antimicrobial Agents and Chemotherapy Journal website
- Volume:
- 59
- Issue:
- 5
- Pages:
- 2756-2764
- Publication date:
- 2015-05-01
- DOI:
- EISSN:
-
1098-6596
- ISSN:
-
0066-4804
- Source identifiers:
-
509854
Item Description
- Language:
- English
- Pubs id:
-
pubs:509854
- UUID:
-
uuid:6fbe72fb-0cd0-474b-84c9-868070083c65
- Local pid:
- pubs:509854
- Deposit date:
- 2015-12-26
Terms of use
- Copyright holder:
- Parry et al
- Copyright date:
- 2015
- Notes:
- Copyright © 2015, Parry et al. This is an open-access article distributed under the terms of theCreative Commons Attribution 3.0 Unported license.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record